Hennes & Mauritz AB : Buying pressure
Entry price | Target | Stop-loss | Potential |
---|
SEK 188.56 |
SEK 220 |
SEK 172 |
+16.67% |
---|
The recent break-out to the upside has created potential for further gains for shares in Hennes & Mauritz.
Summary● In a short-term perspective, the company has interesting fundamentals.
Strengths● This company will be of major interest to investors in search of a high dividend stock.
● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 150.25 SEK
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at SEK 191.6.
● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
● The company benefits from high valuations in earnings multiples.
● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.